This manuscript reports on the application of ribosome profiling (EZRA-seq and eRF1-seq) combined with massively parallel reporter assays to identify and characterize a GA-rich element associated with ...
This paper describes the eccentricity, amplitude, phase shift, angular momentum, polarization, radial path, and orbital ...
Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic ...
The study presents important insights into the regulation of muscle hypertrophy, regulated by Muscle Ankyrin Repeat Proteins (MARPs) and mTOR. The methods are overall solid and complementary, with ...
Top Speed on MSN
Honda Prologue Specifications And Real-World Range
We break down the 2025 Honda Prologue’s specs, range, and performance to see how this all-electric SUV performs in the real world.
Amateur Photographer on MSN
Sony RX1R III review: I really wanted to love this tiny full-frame compact, but I can’t
Sony’s full-frame compact offers fantastic image quality in a tiny body, but it has its drawbacks too, as Andy Westlake finds ...
Q3 2025 revenue of €143.1 million for YORVIPATH® and €50.7 million for SKYTROFA® - Q3 2025 operating profit of €11.0 million - TransCon® CNP (navepegritide) under FDA Priority Review for the ...
Wearables, Mobile Health (m-Health), Real-Time Monitoring Share and Cite: Alqarni, A. (2025) Analysis of Decision Support ...
CEO Jeff Hirsch sees Starz joining the M&A fray with "marooned" linear networks that big owners might not value but could be repositioned for digital.
News-Medical.Net on MSN
Understanding leptin's dual function in MAFLD pathogenesis
Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, ...
Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results